Ken Aitken – Managing Director – Metgasco (ASX:MEL) is a petroleum (oil and gas) exploration and production company, listed on the Australian Securities Exchange.
Copyright 2023 – Finance News Network
Source: Finance News Network
16 Aug 2021 - BluGlass Limited (ASX:BLG) Executive Chair, James Walker and Chief Technology and Operations Officer, Dr Ian Mann discuss the company’s world-first demonstration of working tunnel junction laser diodes created using remote plasma chemical vapour deposition (RPCVD) technology.
Read More22 Jun 2020 - An interview with Andrew Schwartz, Group Managing Director and Chief Investment Officer of Qualitas.
Read More21 Mar 2023 - Aspen Group Limited (ASX:APZ) Executive Director and Joint CEO John Carter provides an introduction to the company, discussing target market, the rising interest rate environment, portfolio mix and development pipeline.
Read More09 March 2023 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses drivers of revenue growth, the roadmap for the company's three SaaS solutions, onshoring GreenOrbit operations and outlook for the second half.
Read More23 May 2023 - Flynn Gold Limited (ASX:FG1) Managing Director Neil Marston discusses the company's portfolio of projects, focusing on the company's gold exploration in north-east Tasmania.
Read More14 Jun 2024 - Elementos Limited (ASX:ELT) Managing Director Joe David discusses a recent agreement to acquire up to a 50% interest in an operating Spanish tin smelter.
Read More28 Feb 2024 - Kula Gold Limited (ASX:KGD) Managing Director Ric Dawson provides an introduction to the company.
Read More11 Aug 2025 - Inside Etherstack’s multi-year partnership with the world’s largest telecom
Read More03 Aug 2020 - Kingston Resources Limited (ASX:KSN) Managing Director Andrew Corbett provides an update on the company's Misima and Livingstone Gold Projects.
Read More30 Nov 2021 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow talks about the recent presentation of data from the CHM 1101 (Chlorotoxin CAR T) Phase 1 clinical trial in glioblastoma patients.
Read More
